Interpace Diagnostics Group, Inc.
(NASDAQ : IDXG)

( )
IDXG PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Servicestothe Health Industry
symbolcompany%chnglast%shortavg$volume
ESRXExpress Scripts Holding Company
-1.12%60.935.7%$192.53m
CERNCerner Corporation
-0.92%64.777.4%$107.50m
QQuintiles Transnational Holdings, Inc.
-0.61%94.154.3%$107.19m
LHLaboratory Corporation of America Holdings
-1.15%153.622.2%$94.32m
DGXQuest Diagnostics Incorporated
-0.11%106.724.2%$86.86m
SRCLStericycle, Inc.
-1.38%70.916.7%$71.97m
ATHNathenahealth, Inc.
-1.66%139.1318.0%$69.64m
HLSHealthSouth Corporation
-0.77%43.7410.4%$43.55m
MDRXAllscripts Healthcare Solutions, Inc.
-0.38%12.979.3%$39.57m
INCRINC Research Holdings, Inc. Class A
-3.25%56.506.5%$36.34m
ABCOAdvisory Board Company
-0.48%51.406.2%$32.31m
HCSGHealthcare Services Group, Inc.
-0.61%50.946.8%$14.83m
OMCLOmnicell, Inc.
-1.70%49.2011.6%$14.52m
AMRIAlbany Molecular Research, Inc.
0.00%21.7215.6%$13.86m
HMSYHMS Holdings Corp.
-1.45%17.631.9%$11.59m

Company Profile

Interpace Diagnostics Group, Inc. provides commercialization services to biopharmaceutical companies. It focuses on developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for patient diagnosis and management. The company offers commercialized molecular tests which include PancraGen, ThyGenX, and ThyraMIR. PancraGen for the diagnosis and prognosis of pancreatic cancer from pancreatic cysts; ThyGenX, for the diagnosis of thyroid cancer from thyroid nodules utilizing a next generation sequencing assay and ThyraMIR, for the diagnosis of thyroid cancer from thyroid nodules utilizing a proprietary gene expression assay. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.